- $1.94bn
- $1.82bn
- $908.40m
- 85
- 53
- 61
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 898 | 803 | 933 | 971 | 908 |
Cost of Revenue | |||||
Gross Profit | 314 | 292 | 349 | 321 | 307 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 841 | 735 | 816 | 827 | 823 |
Operating Profit | 57.3 | 67.3 | 117 | 144 | 85.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 55.1 | 68.5 | 126 | 140 | 76.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 47.3 | 50 | 108 | 117 | 56.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 47.3 | 50 | 108 | 117 | 56.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 47.3 | 50 | 108 | 117 | 56.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.09 | 3.37 | 5.97 | 2.86 | 3.59 |